Arrowhead Pharmaceuticals, Inc. (ARWR)
70.09
-0.73
(-1.03%)
USD |
NASDAQ |
Dec 12, 16:00
69.72
-0.37
(-0.53%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Research and Development Expense (TTM): 585.26M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Sarepta Therapeutics, Inc. | 1.389B |
| Ionis Pharmaceuticals, Inc. | 879.75M |
| Alnylam Pharmaceuticals, Inc. | 1.248B |
| Amgen, Inc. | 6.828B |
| Pfizer Inc. | 10.13B |